Simultaneous analytical method [Bioanalytics]

posted by Ohlbe – France, 2018-09-13 14:06 (948 d 12:14 ago) – Posting: # 19287
Views: 2,673

Dear giang nidqc

» Could it be a possibility that the absence of one APIs may affect the final concentration of other APIs (regarding sample preparation and peak response)?

I agree with Helmut's post above. There is just one thing I'm thinking of: how was the spiking of calibration and QC samples done when you used 5 analytes ? Did you use a single spiking solution containing all analytes (usual practice), or separate working solutions ? If you used a single, combined solution at each level concentration, no problem. If you used separate spiking solutions, you will have a different proportion of solvent added to the plasma if you have less analytes, which may influence your recovery and matrix effects.

Regards
Ohlbe

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,509 registered users;
online 13 (0 registered, 13 guests [including 5 identified bots]).
Forum time: Monday 02:20 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5